NO933465D0 - Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling - Google Patents

Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling

Info

Publication number
NO933465D0
NO933465D0 NO933465A NO933465A NO933465D0 NO 933465 D0 NO933465 D0 NO 933465D0 NO 933465 A NO933465 A NO 933465A NO 933465 A NO933465 A NO 933465A NO 933465 D0 NO933465 D0 NO 933465D0
Authority
NO
Norway
Prior art keywords
indazol
tetrahydro
derivatives
procedure
preparation
Prior art date
Application number
NO933465A
Other languages
English (en)
Other versions
NO933465L (no
Inventor
Wolfgang Eberlein
Wolfgang Engel
Gerhard Mihm
Klaus Rudolf
Guenther Engelhardt
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO933465D0 publication Critical patent/NO933465D0/no
Publication of NO933465L publication Critical patent/NO933465L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Toys (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO933465A 1992-09-29 1993-09-28 Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling NO933465L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4232544A DE4232544A1 (de) 1992-09-29 1992-09-29 Arzneimittel enthaltend 1,5,6,7-Tetrahydro-4H-indazol-4-one, neue 1,5,6,7-Tetrahydro-4H-indazol-4-one und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
NO933465D0 true NO933465D0 (no) 1993-09-28
NO933465L NO933465L (no) 1994-03-30

Family

ID=6469076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933465A NO933465L (no) 1992-09-29 1993-09-28 Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling

Country Status (20)

Country Link
US (1) US5468766A (no)
EP (1) EP0590558B1 (no)
JP (1) JPH06211802A (no)
KR (1) KR940006588A (no)
CN (1) CN1088434A (no)
AT (1) ATE131053T1 (no)
AU (1) AU667237B2 (no)
BG (1) BG98125A (no)
CA (1) CA2107026A1 (no)
CZ (1) CZ203193A3 (no)
DE (2) DE4232544A1 (no)
EE (1) EE9400233A (no)
FI (1) FI934252A (no)
HU (1) HUT67452A (no)
IL (1) IL107142A0 (no)
NO (1) NO933465L (no)
NZ (1) NZ248773A (no)
PL (1) PL300522A1 (no)
SK (1) SK94593A3 (no)
ZA (1) ZA937179B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795584B2 (en) 2013-07-30 2017-10-24 University Of South Florida Treating an atypical protein kinase C enzyme abnormality

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3691180A (en) * 1970-07-31 1972-09-12 Ciba Geigy Corp Cycloalkano (c)pyrazoles
KR880009024A (ko) * 1987-01-27 1988-09-13 게리 디.스트리트 기관지 확장제용 디피라졸
DE4024862A1 (de) * 1990-08-04 1992-02-13 Hoechst Ag 4,5,6,7-tetrahydro-3-aryl-indazole, verfahren zu ihrer herstellung und ihre verwendung als herbizide
US5108485A (en) * 1990-08-31 1992-04-28 American Cyanamid Company Herbicidal 2-(2-imidazolin-2-yl)-benzazoles

Also Published As

Publication number Publication date
ATE131053T1 (de) 1995-12-15
KR940006588A (ko) 1994-04-25
IL107142A0 (en) 1993-12-28
CZ203193A3 (en) 1994-04-13
NZ248773A (en) 1995-07-26
HU9302750D0 (en) 1993-12-28
JPH06211802A (ja) 1994-08-02
PL300522A1 (en) 1994-04-05
FI934252A (fi) 1994-03-30
US5468766A (en) 1995-11-21
CN1088434A (zh) 1994-06-29
CA2107026A1 (en) 1994-03-30
EP0590558A1 (de) 1994-04-06
ZA937179B (en) 1995-06-28
HUT67452A (en) 1995-04-28
AU667237B2 (en) 1996-03-14
SK94593A3 (en) 1994-09-07
EP0590558B1 (de) 1995-12-06
AU4863993A (en) 1994-04-14
FI934252A0 (fi) 1993-09-28
DE59301096D1 (de) 1996-01-18
EE9400233A (et) 1996-02-15
BG98125A (en) 1994-06-30
NO933465L (no) 1994-03-30
DE4232544A1 (de) 1994-03-31

Similar Documents

Publication Publication Date Title
NO921835D0 (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
SE8700499L (sv) Nya farmakologiskt aktiva foreningar
NO306346B1 (no) N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
SE8106425L (sv) Nya derivat av nor-tropan och granatan, deras framstellningssett och deras terapeutiska anvendning
DK0380063T3 (da) 1,2-Cyclohexylaminoarylamider til anvendelse som analgetika
FI893433A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
NO305554B1 (no) Nye bis-naftalimider og farmas°ytisk blanding for behandling av kreft
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
NO881308D0 (no) Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
NO933465D0 (no) Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
DE59004292D1 (de) Renin-hemmende Aminooligohydroxy-Derivate.
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them